Prospective Subtalar, Double, or Triple Arthrodesis Study With CCS Screws

Sponsor
Duke University (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT02619838
Collaborator
(none)
50
1
98.7
0.5

Study Details

Study Description

Brief Summary

The objective of this study is to prospectively evaluate the mid-term results and intraoperative and postoperative complication rate in patients who underwent double or triple arthrodesis using CCS screws.

Condition or Disease Intervention/Treatment Phase
  • Device: Aptus CCS 5.0 or/and 7.0 screws

Detailed Description

This proposal is a collaborative effort of Medartis. This is a prospective investigation to evaluate the mid-term results and intraoperative and postoperative complication rate in patients who underwent subtalar,double or triple arthrodesis using CCS screws.The assignment of the device is at the discretion of the standard of care provider, not the study investigator.

Patients undergoing a double or triple arthrodesis in their foot using Aptus CCS screws will be asked to enroll in this study. After informed consent, the patients will be asked to complete the following patient reported outcomes questionnaires (standard of care for all patients in the Foot and Ankle section): VAS for pain, modified Coughlin rating scale, AOFAS, and FADI at each standard of care visit which includes preoperative, 6 weeks, 3 months, 6 months, 1 year, and 2 years post operative. Patients will also receive standard of care radiographs at these visits, and a standard of care CT scan at 6 months.

Patients will be identified in the clinic by an attending orthopaedic foot and ankle surgeon or his physician assistant based on clinical exam and radiographic findings. Inclusion criteria include anyone over age 18 who has Rheumatoid or posttraumatic osteoarthritis of the hindfoot with involvement of subtalar, talonavicular, and calcaneocuboid joints, and/or Symptomatic rigid pes planovalgus et abductus with end-stage posterior tibial tendon dysfunction, and/or Neuromuscular disease mediated hindfoot deformities, and/or Tarsal coalitions, and/or Indication for calcaneocuboid arthrodesis: severe degenerative changes in the calcaneocuboid joint and/or severe abductus deformity of the forefoot.and has failed nonoperative management. Typically, these patients have multiple medical comorbidities and therefore the only exclusion criteria will be patients who are not healthy enough to undergo surgery. Approximately 50 patients will be recruited for the study.

Study Design

Study Type:
Observational
Actual Enrollment :
50 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Prospective Subtalar, Double, or Triple Arthrodesis Study With CCS Screws
Actual Study Start Date :
Oct 7, 2015
Anticipated Primary Completion Date :
Dec 29, 2023
Anticipated Study Completion Date :
Dec 29, 2023

Arms and Interventions

Arm Intervention/Treatment
Aptus CCS 5.0 or/and 7.0 screws

Procedure/Surgery: Subtalar, Double or Triple Arthrodesis of the talonavicular joint, the subtalar joint, and the calcaneal-cuboid joint of the foot with the Aptus CCS 5.0 or/and 7.0 screws

Device: Aptus CCS 5.0 or/and 7.0 screws
Fusion of the talonavicular joint, the subtalar joint, and the calcaneal-cuboid joint with a Aptus CCS screws. The assignment of the device is at the discretion of the standard of care provider, not the study investigator.

Outcome Measures

Primary Outcome Measures

  1. The rate of intraoperative complications. [Surgery]

    All intraoperative complications including injury of neurovascular structures and/or tendons will be prospectively documented. All intraoperative technical difficulties (for example, breakage of the screw) will be prospectively documented. The rate of the intraoperative complications will be calculated by an independent observer.

  2. The rate of perioperative complications. [Surgery up to 2 years post operative.]

    All perioperative complications including wound healing problems and/or superficial/deep infection and/or deep vein thrombosis will be prospectively documented. The rate of the perioperative complications will be calculated by an independent observer.

  3. The rate of delayed osseous union or non-union. [Surgery up to 2 years post operative]

    Independent radiologist will measure fusion of standard of care radiographs and CT scan

  4. The fixation of a double or triple arthrodesis neutral hindfoot alignment. [Surgery up to 2 years post operative]

    An independent radiologist will measure fusion of the double, triple, or subtalar fusion by reviewing the standard of care radiographs and CT scan and measuring the rate of fusion using the bridging of the trabecular bone.

  5. The double or triple arthrodesis in substantial pain relief [Pre-operative to 2 years post operative]

    VAS

  6. The double or triple arthrodesis will result in substantial functional improvement, as measured by the American Orthopaedic Foot and Ankle Society (AOFAS) hindfoot score [Pre-operative to 2 years post operative]

    The functional status will be assessed using the American Orthopaedic Foot and Ankle Society (AOFAS) hindfoot score and Foot & Ankle Disability Index (FADI) score preoperatively and postoperatively at all follow-ups 6 weeks, 3 months, 6 months, 1 year, and 2 years.

  7. The double or triple arthrodesis will result in substantial functional improvement, as measured by the Foot & Ankle Disability Index (FADI) score [Pre-operative to 2 years post operative]

    The functional status will be assessed using the American Orthopaedic Foot and Ankle Society (AOFAS) hindfoot score and Foot & Ankle Disability Index (FADI) score preoperatively and postoperatively at all follow-ups 6 weeks, 3 months, 6 months, 1 year, and 2 years.

  8. The rate of secondary surgical procedures for any reason including hardware removal [Surgery up to 2 years post operative]

    All postoperative complications requiring any secondary surgical procedures including hardware removal will be prospectively documented. The rate of the perioperative complications will be calculated by an independent observer.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Rheumatoid or posttraumatic osteoarthritis of the hindfoot with involvement of subtalar, talonavicular, and calcaneocuboid joints (2;12).

  • Symptomatic rigid pes planovalgus et abductus with end-stage posterior tibial tendon dysfunction (e.g. grade IV) (4;13-15).

  • Neuromuscular disease mediated hindfoot deformities (16).

  • Tarsal coalitions (17).

  • Indication for calcaneocuboid arthrodesis: severe degenerative changes in the calcaneocuboid joint and/or severe abductus deformity of the forefoot.

  • Between the age 18-75

Exclusion Criteria:
  • Acute or chronic infection.

  • Poor vascular status of the lower leg (relative contraindication for double arthrodesis through a single medial approach).

  • Women that are pregnant.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Duke University Medical Center Durham North Carolina United States 27703

Sponsors and Collaborators

  • Duke University

Investigators

  • Principal Investigator: Mark E. Easley, MD, Duke Health

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Duke University
ClinicalTrials.gov Identifier:
NCT02619838
Other Study ID Numbers:
  • Pro00059296
First Posted:
Dec 2, 2015
Last Update Posted:
May 6, 2022
Last Verified:
May 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by Duke University
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 6, 2022